ST Sairon Establishes Pharmaceutical Technology Development Subsidiary in Shanghai

According to the Qichacha APP, recently, Shanghai Mixi Medical Technology Development Co., Ltd. was established with a registered capital of 10 million yuan. Its business scope includes production and sales of Class I and Class II medical devices. The equity penetration displayed on Qichacha shows that the company is wholly owned by *ST Sailong.